Ju Guo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Circular RNAs in diseases 5
- Melanoma and MAPK Pathways 3
-
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 5
- Renal cell carcinoma treatment 3
- Co-authors
- Bin Fu (14 shared papers)Gongxian Wang (6 shared papers)Jieping Hu (7 shared papers)Wei Huang (2 shared papers)Xiaocheng Zhou (2 shared papers)Yuanyuan Li (1 shared paper)Cheng Zhang (1 shared paper)Jun Deng (4 shared papers)
- Journals
- Medicine (2 papers)Frontiers in Oncology (2 papers)Cell Death and Disease (2 papers)Molecular Cancer (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Ju Guo
38 papers receiving 480 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 149
- Pulmonary and Respiratory Medicine 134
- Molecular Biology 235
- Oncology 54
- Urology 10
Countries citing papers authored by Ju Guo
This map shows the geographic impact of Ju Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Guo more than expected).
Fields of papers citing papers by Ju Guo
This network shows the impact of papers produced by Ju Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Guo. The network helps show where Ju Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 93 | |
| 2 | 2019 | 41 | |
| 3 | 2017 | 40 | |
| 4 | 2017 | 34 | |
| 5 | 2021 | 27 | |
| 6 | 2020 | 23 | |
| 7 | 2022 | 23 | |
| 8 | 2015 | 18 | |
| 9 | 2017 | 17 | |
| 10 | 2019 | 14 | |
| 11 | 2018 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 8 | |
| 18 | 2018 | 8 | |
| 19 | 2023 | 7 | |
| 20 | 2022 | 7 |
About Ju Guo
Ju Guo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Oncology, having authored 42 papers that have together received 482 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers), Circular RNAs in diseases (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Cutaneous Melanoma Detection and Management (4 papers), MicroRNA in disease regulation (4 papers), Renal cell carcinoma treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Cancer Research (149 citations), Pulmonary and Respiratory Medicine (134 citations), Molecular Biology (235 citations), Oncology (54 citations) and Urology (10 citations). Ju Guo has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Bin Fu, Gongxian Wang, Jieping Hu, Wei Huang, Xiaocheng Zhou, Yuanyuan Li, Cheng Zhang, Jun Deng, Luyao Chen and Xiaoqiang Liu. Their work appears in journals such as Medicine, Frontiers in Oncology, Cell Death and Disease, Molecular Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.